How close are we to a cure for Hunter Syndrome?

A new FDA-approved treatment for Hunter syndrome (MPS II) is giving families hope, but it’s not a cure. We explore how close researchers may be to a cure, including promising gene therapy clinical trials, and what experts say still needs long-term study.

00:00 intro
00:45 How this story began: a mom reaches out about newly approved Avlayah.
01:03 Why it matters: therapy designed to cross the blood-brain barrier.
01:20 The emotional center: two moms bond while navigating the same diagnosis.
02:23 Hunter syndrome (MPS II) explained: missing enzyme, sugar buildup, organ/brain damage.
03:40 How the “next-gen” enzyme replacement works using an enzyme transport vehicle.
04:16 Early impact: reported behavioral/physical improvements and infusion-center support.
05:36 “Not a cure” → what a cure could look like; intro to gene therapy.
06:23 London trial spotlight: one-time ex vivo gene therapy; early (anecdotal) improvements. https://www.gosh.nhs.uk/news/gosh-manufactures-new-gene-therapy-for-rare-condition/
08:01 U.S. clinical trial in New Jersey: timelines and what’s still unknown. https://clinicaltrials.gov/study/NCT07236606
08:48 Physician Assistant Laura Buch: long-term durability, dosing questions, and rare-disease trial limits.
10:03 Advocacy + how to find trials on ClinicalTrials.gov; closing thoughts.
https://clinicaltrials.gov/study/NCT03566043

The Wellness Files is a health-focused podcast where we explore practical tools, research and real patient stories. We hope to inform, inspire, and connect to audiences so you can be the best version of yourself, while also asking tough questions about safety and effectiveness.